Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...

There will be about 299,010 new cases of prostate cancer diagnosed this year, according to the American Cancer Society.

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

The Streetjournal Magazine is an online investigating media house that specializes on systematic, serious crimes, political ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...

A groundbreaking new cancer treatment, hailed by patients as "game-changing", will be available via the NHS from today.

A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.

A team of University of Kentucky Markey Cancer Center researchers have found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug treatment.

Former Bachelorette star Katie Thurston is sharing a major update on her cancer journey after having to put her treatments on ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...